The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Open accessAbstract
Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with a 5-year survival rate of 4%. A key hallmark of PDAC is extensive stromal involvement, which makes capturing precise tumor-specific molecular information difficult. Here we have overcome this problem by applying blind source separation to a diverse collection of PDAC gene expression microarray data, including data from primary tumor, metastatic and normal samples. By digitally separating tumor, stromal and normal gene expression, we have identified and validated two tumor subtypes, including a 'basal-like' subtype that has worse outcome and is molecularly similar to basal tumors in bladder and breast cancers. Furthermore, we define 'normal' and 'activated' stromal subtypes, which are independently prognostic. Our results provide new insights into the molecular composition of PDAC, which may be used to tailor therapies or provide decision support in a clinical setting where the choice and timing of therapies are critical.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moffit and colleagues devised a “virtual dissection strategy” to computationally subtract the transcriptional background imposed by stromal and immune cells from bulk-RNA sequencing signatures131. Using this approach, they identified two subtypes of PDAC tumors, termed “classical” and “basal-like”, in addition to two stromal subtypes termed “normal stroma” and “activated stroma”.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [131]
In the citing paper
“The dichotomous Moffitt classification schema of “basal-like” and “classical” subtypes was initially established using bulk RNA sequencing strategies applied to human tumor samples (Moffitt 2015)36.”
From Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution (2022) · cites this paper as Moffitt 2015
In the citing paper
“The dichotomous Moffitt classification schema of “basal-like” and “classical” subtypes was initially established using bulk RNA sequencing strategies applied to human tumor samples (Moffitt 2015)36.”
From Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution (2022) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Trapnell, C., Roberts, A., Goff, L. A., Pertea, G. M., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,145
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778
Self-citationSignatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
The Reactome pathway Knowledgebase
Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,605
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S. C. Y., Voduc, D. K., Vickery, T. L., Davies, S. R., Fauron, C. M. ‐., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,818
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,002
Pitter, K. L., Grbovic-Huezo, O., Joost, S., Singhal, A., Blum, M., Wu, K., Holm, M., Ferrena, A., Bhutkar, A. J., Hudson, A., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1742 · Cited by 35
Self-citationClinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Skorupan, N., Domínguez, M. P., Ricci, S. L., & Alewine, C. (2022) · Cancers · doi:10.3390/cancers14174209 · Cited by 35
Masuda, S., Koizumi, K., Shionoya, K., Jinushi, R., Makazu, M., Nishino, T., Kimura, K. A., Sumida, C., Kubota, J., Ichita, C., et al. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i12.1863 · Cited by 33
Yang, J., Ren, B., Ren, J., Yang, G., Fang, Y., Wang, X., Zhou, F., You, L., & Zhao, Y.-P. (2023) · Journal of experimental & clinical cancer research : CR · doi:10.1186/s13046-023-02698-x · Cited by 28
Samain, R., Maiques, Ó., Monger, J., Lam, H., Candido, J. B., George, S. L., Ferrari, N., KohIhammer, L., Lunetto, S., Varela-Vázquez, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.adi0244 · Cited by 35
Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors
Bear, A. S., Nadler, R. B., O’Hara, M. H., Stanton, K. L., Xu, C. B., Saporito, R., Rech, A. J., Baroja, M. L., Blanchard, T., Elliott, M. H., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175790 · Cited by 35
Molecular or Metabolic Reprograming: What Triggers Tumor Subtypes?
Eason, K., & Sadanandam, A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0141 · Cited by 33
From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
Bazzichetto, C., Conciatori, F., Luchini, C., Simionato, F., Santoro, R., Vaccaro, V., Corbo, V., Falcone, I., Ferretti, G., Cognetti, F., et al. (2020) · Cells · doi:10.3390/cells9020309 · Cited by 32
Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers
Mantini, G., Vallés‐Martí, A., Large, T. Y. S. L., Capula, M., Funel, N., Pham, T. V., Piersma, S. R., Geert Kazemier, M., Bijlsma, M. F., Giovannetti, E., et al. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00548-y · Cited by 34
Samain, R., Brunel, A., Douché, T., Fanjul, M., Cassant‐Sourdy, S., Rochotte, J., Cros, J. F., Neuzillet, C., Raffenne, J., Duluc, C., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.01.008 · Cited by 32
Abt, E. R., Le, T. M., Dann, A. M., Capri, J. R., Poddar, S., Lok, V. M., Li, L., Liang, K., Creech, A. L., Rashid, K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110236 · Cited by 33
Shen, C., Yan, T., Liu, W. C., Zhu, X., Tian, X., Fu, X., Hua, R., Zhang, J., Huo, Y., Liu, D., et al. (2017) · Journal of Cancer · doi:10.7150/jca.20086 · Cited by 33
Hwang, W. L., Jagadeesh, K. A., Guo, J. A., Hoffman, H. I., Yadollahpour, P., Mohan, R. R., Drokhlyansky, E., Wittenberghe, N. V., Ashenberg, O., Farhi, S. L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.25.267336 · Cited by 35
Furuhashi, S., Bustos, M. A., Mizuno, S., Ryu, S., Naeini, Y. B., Bilchik, A. J., & Hoon, D. S. �. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00474-w · Cited by 33
Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma
Joseph, A. M., Aiyan, A. A., al-Ramadi, B. K., Singh, S. K., & Kishore, U. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1323198 · Cited by 36
Haab, B. B., Qian, L., Staal, B., Jain, M., Fahrmann, J. F., Worthington, C., Prosser, D., Velokokhatnaya, L., Lopez, C., Tang, R., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217245 · Cited by 32
Cancer‐associated fibroblast‐derived MMP11 promotes tumor progression in pancreatic cancer
Wang, Z., Guo, X., Li, X., Wang, J., Zhang, N., Amin, B., Xu, G., & Zhu, B. (2024) · Cancer Science · doi:10.1111/cas.16418 · Cited by 32
A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer
Renouf, D. J., Hedley, D. W., Krzyzanowska, M. K., Schmuck, M., Wang, L., & Moore, M. J. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3102-y · Cited by 32
Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma
Xu, Z., Zhao, M., Chen, W., Li, K., Qin, F., Xiang, W., Sun, Y., Wei, J., Yuan, L., Li, S., et al. (2020) · PeerJ · doi:10.7717/peerj.9530 · Cited by 32
Jain, P., Dvorkin‐Gheva, A., Mollen, E., Malbeteau, L., Xie, M. H., Jessa, F., Dhavarasa, P., Chung, S., Brown, K. R., Jang, G. H., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf7114 · Cited by 33
The Landmark Series: Preoperative Therapy for Pancreatic Cancer
Patel, S. H., Katz, M. H. G., & Ahmad, S. A. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10075-1 · Cited by 32
Dardare, J., Witz, A., Merlin, J., Bochnakian, A., Toussaint, P., Gilson, P., & Harlé, A. (2021) · Pharmaceuticals · doi:10.3390/ph14080740 · Cited by 33
Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting
Pappalardo, A., Giunta, E. F., Tirino, G., Pompella, L., Federico, P., Daniele, B., Vita, F. D., & Petrillo, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.695627 · Cited by 32
Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer
Wandmacher, A. M., Letsch, A., & Sebens, S. (2021) · Cancers · doi:10.3390/cancers13164235 · Cited by 33
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)
Zuzčák, M., & Trnka, J. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5383 · Cited by 33
Shinkawa, T., Ohuchida, K., & Nakamura, M. (2022) · Cancers · doi:10.3390/cancers14163994 · Cited by 32
Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic
Du, Y., Zhao, B., Liu, Z., Ren, X., Zhao, W., Li, Z., You, L., & Zhao, Y. (2017) · Journal of Cancer · doi:10.7150/jca.17622 · Cited by 32
Carpenter, E. S., Kadiyala, P., Elhossiny, A. M., Kemp, S. B., Li, J., Steele, N. G., Nicolle, R., Nwosu, Z. C., Freeman, J., Dai, H., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1421 · Cited by 32
Lencioni, G., Gregori, A., Toledo, B., Rebelo, R., Immordino, B., Amrutkar, M., Xavier, C. P. R., Kocijancic, A., Pandey, D. P., Perán, M., et al. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.09.002 · Cited by 32
Seo, J., Lee, J., Kim, A., Shin, J.-Y., Jung, Y. J., Lee, S. B., Kim, Y. H., Park, S., Lee, H. J., Park, I. K., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0453 · Cited by 31
Hall, B. R., Cannon, A. C., Thompson, C. M., Santhamma, B., Chávez‐Riveros, A., Bhatia, R., Nair, H. B., Nickisch, K. J., Batra, S. K., & Sushil Kumar, K. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.184 · Cited by 32
Gene Targeting in Disease Networks
Weighill, D. A., Guebila, M. B., Glass, K., Platig, J., Yeh, J. J., & Quackenbush, J. F. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.649942 · Cited by 30
Self-citationZhang, W., Tang, Y., Guo, Y., Kong, Y., Shi, F., Sheng, C., Wang, S., & Wang, Q. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00292-6 · Cited by 33
Suurmeijer, J. A., Soer, E. C., Dings, M. P. G., Kim, Y., Strijker, M., Bonsing, B. A., Brosens, L. A. A., Busch, O. R., Groen, J. V., Halfwerk, J. B. G., et al. (2022) · British journal of surgery · doi:10.1093/bjs/znac272 · Cited by 30
Lumibao, J. C., Okhovat, S. R., Peck, K. L., Lin, X., Lande, K., Yomtoubian, S., Ng, I., Tiriac, H., Lowy, A. M., Zou, J., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.172419 · Cited by 30
Pancreatic ductal adenocarcinoma (PDAC): clinical progress in the last five years
Mosalem, O. M., Abdelhakeem, A. A. F., Abdel-Razeq, N. H., & Babiker, H. M. (2025) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2025.2473698 · Cited by 33
Ji, S., Cao, L., Gao, J., Du, Y., Zeng, Y., Lou, X., Liu, F., Zhang, Y., Xu, J., Shi, X., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.016 · Cited by 32
Al-Hilal, T. A., Chrysovergi, M.-A., Grasberger, P. E., Liu, F., Auernheimer, V., Zhou, Y., Xiao, Z., Duque, M. A. L., Santos, A., Islam, T., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01697-8 · Cited by 36
Chiramel, J., Backen, A. C., Pihlak, R., Lamarca, Á., Frizziero, M., Tariq, N.-U.-A., Hubner, R. A., Valle, J. W., Amir, E., & McNamara, M. G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050909 · Cited by 30
Wang, Y., Park, J. Y. P., Pacis, A., Denroche, R. E., Jang, G. H., Zhang, A. X. W., Cuggia, A., Domecq, C., Monlong, J., Raitses‐Gurevich, M., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1439 · Cited by 29
Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence
Sántha, P., Lenggenhager, D. M., Finstadsveen, A. V., Dorg, L. T., Tøndel, K., Amrutkar, M., Gladhaug, I. P., & Verbeke, C. S. (2021) · Cancers · doi:10.3390/cancers13040895 · Cited by 33
PRMT5: An Emerging Target for Pancreatic Adenocarcinoma
Lee, M. K. C., Grimmond, S. M., McArthur, G. A., & Sheppard, K. E. (2021) · Cancers · doi:10.3390/cancers13205136 · Cited by 30
Rozengurt, E., & Eibl, G. (2021) · Cancers · doi:10.3390/cancers13205126 · Cited by 31
Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2
Yang, H., Li, Z., Zhu, S., Wang, W., Zhang, J., Zhao, D., Zhang, M., Zhu, W., Xu, W., & Xu, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1347683 · Cited by 30
Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution
Monberg, M. E., Geiger, H., Lee, J. J., Sharma, R., Semaan, A., Bernard, V., Wong, J., Wang, F., Liang, S., Swartzlander, D. B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31376-3 · Cited by 30
Benkhaled, S., Peters, C., Jullian, N., Arsenijevic, T., Navez, J., Gestel, D. V., Moretti, L., Laethem, J. V., & Bouchart, C. (2023) · Cancers · doi:10.3390/cancers15030768 · Cited by 29
Xu, W., Zhang, W., Zhao, D., Wang, Q., Zhang, M., Li, Q., Zhu, W., & Xu, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1242909 · Cited by 31
Inhibiting stromal Class I HDACs curbs pancreatic cancer progression
Liang, G., Oh, T. G., Hah, N., Tiriac, H., Shi, Y., Truitt, M., Antal, C. E., Atkins, A. R., Li, Y., Fraser, C. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42178-6 · Cited by 32
Ruta, V., Naro, C., Pieraccioli, M., Leccese, A., Archibugi, L., Cesari, E., Panzeri, V., Allgöwer, C., Arcidiacono, P. G., Falconi, M., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101411 · Cited by 29
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease
Filippini, D., D’Agosto, S. L., Delfino, P., Simbolo, M., Piro, G., Rusev, B. C., Veghini, L., Cantù, C., Lupo, F., Ugel, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48663-7 · Cited by 30
Ramu, I., Buchholz, S. M., Patzak, M. S., Goetze, R. G., Singh, S. K., Richards, F. M., Jodrell, D. I., Sipos, B., Ströbel, P., Ellenrieder, V., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.024 · Cited by 29
Palacio, S., McMurry, H. S., Ali, R. A., Donenberg, T. R., Silva‐Smith, R., Wideroff, G. A., Sussman, D. A., Lima, C. M. S. R., & Hosein, P. J. (2019) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2019.09.12 · Cited by 29
Glaß, M., Michl, P., & Hüttelmaier, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114190 · Cited by 29
Current methods in translational cancer research
Lee, M. W., Miljanic, M., Triplett, T., Ramírez, C., Aung, K. L., Eckhardt, S., & Capasso, A. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09931-5 · Cited by 32
Targeting SRC Kinase Signaling in Pancreatic Cancer Stem Cells
Alcalá, S., Mayoral-Varo, V., Ruíz-Cañas, L., López-Gil, J. C., Heeschen, C., Martı́n-Pérez, J., & Sáinz, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207437 · Cited by 29
Martínez‐Useros, J., Martin-Galan, M., & García‐Foncillas, J. (2021) · Cancers · doi:10.3390/cancers13020322 · Cited by 29
Tarasiuk, A., Mackiewicz, T., Malecka-Panas, E. I., & Fichna, J. (2021) · Cancer Biology & Therapy · doi:10.1080/15384047.2021.1941584 · Cited by 29
S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives
Wu, Y., Zhou, Q., Guo, F., Chen, M., Tao, X., & Dong, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.711180 · Cited by 30
Subtyping for pancreatic cancer precision therapy
Huang, X., Zhang, G., & Liang, T. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.03.005 · Cited by 32
Han, S., Gonzalo, D. H., Feely, M., Delitto, D., Behrns, K. E., Beveridge, M. J., Zhang, D., Thomas, R. M., Trevino, J. G., Schmittgen, T. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10722 · Cited by 29
Retinoic acid, CYP26, and drug resistance in the stem cell niche
Alonso, S., Jones, R. J., & Ghiaur, G. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.07.004 · Cited by 29
Unraveling cancer lineage drivers in squamous cell carcinomas
Guan, Y., Wang, G., Fails, D. M., Nagarajan, P., & Ge, Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107448 · Cited by 30
Chen, K., Ma, Y., Zhong, X., Lan, J., Di, L., Tian, X., Yang, Y., & Yang, Y. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216586 · Cited by 28
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC
Lupo, F., Pezzini, F., Pasini, D., Fiorini, E., Adamo, A., Veghini, L., Bevere, M., Frusteri, C., Delfino, P., D’Agosto, S. L., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-329807 · Cited by 28
Chen, Y., Zhang, W., Zeng, Y., Yang, P., Li, Y., Liang, X., Liu, K., Lin, H., Dai, Y., Zhou, J., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03102-4 · Cited by 29
Cencioni, C., Malatesta, S., Benedetti, V. V., Licursi, V., Perfetto, L., Conte, F., Ranieri, D., Bartolazzi, A., Kunkl, M., Tuosto, L., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03263-w · Cited by 31
Alver, T. N., Bergholtz, H., Holm, M. B., Dorg, L. T., Skrede, M. L., Kure, E. H., & Verbeke, C. S. (2025) · Modern Pathology · doi:10.1016/j.modpat.2025.100726 · Cited by 28
The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells
Barnett, D., Liu, Y., Partyka, K. A., Huang, Y., Tang, H., Hostetter, G. H., Brand, R. E., Singhi, A. D., Drake, R. R., & Haab, B. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-04164-z · Cited by 28
Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer
Birnbaum, D. J., Bertucci, F., Finetti, P., Birnbaum, D., & Mamessier, É. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.02.001 · Cited by 29
Bornschein, J., Wernisch, L., Secrier, M., Miremadi, A., Perner, J., MacRae, S., O’Donovan, M., Newton, R., Menon, S., Bower, L., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32384 · Cited by 31
Dorn, Á., Glaß, M., Neu, C. T., Heydel, B., Hüttelmaier, S., Gutschner, T., & Hämmerle, M. (2020) · Cancers · doi:10.3390/cancers12051227 · Cited by 27
Sohal, D. P. S., Krishnamurthi, S., Tohmé, R., Gu, X., Lindner, D. J., Landowski, T. H., Pink, J. J., Radivoyevitch, T., Fada, S., Lee, Z., et al. (2020) · PubMed Central · Cited by 28
Oshi, M., Tokumaru, Y., Patel, A. P., Yan, L., Matsuyama, R., Endo, I., Katz, M. H. G., & Takabe, K. (2020) · Cancers · doi:10.3390/cancers12123635 · Cited by 28
Miyabayashi, K., Nakagawa, H., & Koike, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682872 · Cited by 28
Merali, N., Chouari, T. A. M., Kayani, K., Rayner, C. J., Jiménez, J. I., Krell, J., Giovannetti, E., Bagwan, I., Relph, K., Rockall, T., et al. (2022) · Cancers · doi:10.3390/cancers14041020 · Cited by 29
Shichi, Y., Gomi, F., Sasaki, N., Nonaka, K., Arai, T., & Ishiwata, T. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050746 · Cited by 27
Fraunhoffer, N. A., Abuelafia, A. M., Bigonnet, M., Gayet, O., Roques, J., Nicolle, R., Lomberk, G. A., Urrutia, R. A., Dusetti, N., & Iovanna, J. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00299-z · Cited by 28
Kokumai, T., Omori, Y., Ishida, M., Ohtsuka, H., Mizuma, M., Nakagawa, K., Maeda, C., Ono, Y., Mizukami, Y., Miura, S., et al. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100102 · Cited by 28
Kuhlmann, L., Nadler, W. M., Kerner, A., Hanke, S., Noll, E. M., Eisen, C., Espinet, E., Vogel, V., Trumpp, A., Sprick, M. R., et al. (2016) · Pancreas · doi:10.1097/mpa.0000000000000743 · Cited by 28
Kong, L., Liu, P., Zheng, M., Xue, B., Liang, K., & Tan, X. (2020) · Epigenomics · doi:10.2217/epi-2019-0374 · Cited by 28
ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
Benitz, S., Steep, A., Nasser, M. M., Preall, J. B., Mahajan, U. M., McQuithey, H., Loveless, I. M., Davis, E. T., Wen, H.-J., Long, D. W., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0137 · Cited by 29
Parker, S. J., Chen, L., Spivia, W. R., Saylor, G., Mao, C., Venkatraman, V., Holewinski, R. J., Mastali, M., Pandey, R., Athas, G., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00118 · Cited by 27
Birnbaum, D. J., Begg, S. K. S., Finetti, P., Vanderburg, C. R., Kulkarni, A. S., Neyaz, A., Hank, T. P., Tai, E. C., Deshpande, V., Bertucci, F., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1039 · Cited by 27
Milan, M., Diaferia, G. R., & Natoli, G. (2021) · The EMBO Journal · doi:10.15252/embj.2020107206 · Cited by 27
Jeong, Y. J., Knútsdóttir, H., Shojaeian, F., Lerner, M. G., Wissler, M. F., Henriet, E., Ng, T., Datta, S., Navarro-Serer, B., Chianchiano, P. E., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162054 · Cited by 27
CFTR Expression Analysis for Subtyping of Human Pancreatic Cancer Organoids
Hennig, A., Wolf, L., Jahnke, B., Polster, H., Seidlitz, T., Werner, K., Aust, D. E., Hampe, J., Distler, M., Weitz, J., et al. (2019) · Stem Cells International · doi:10.1155/2019/1024614 · Cited by 27
Speeding towards individualized treatment for pancreatic cancer by taking an alternative road
Iovanna, J., & Dusetti, N. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.016 · Cited by 26
ERO1L promotes pancreatic cancer cell progression through activating the Wnt/catenin pathway
Han, F., Xu, Q., Zhao, J., Peng, X., & Liu, J. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27155 · Cited by 26
Pancreatic Progenitors and Organoids as a Prerequisite to Model Pancreatic Diseases and Cancer
Hohwieler, M., Müller, M., Frappart, P., & Heller, S. (2019) · Stem Cells International · doi:10.1155/2019/9301382 · Cited by 27
Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA
Gao, C., Wisniewski, L., Liu, Y., Staal, B., Beddows, I., Plenker, D., Aldakkak, M., Hall, J., Barnett, D., Gouda, M. K., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2475 · Cited by 26
Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer
Ostios-García, L., Villamayor, J., Garcia-Lorenzo, E., Viñal, D., & Feliú, J. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i40.6775 · Cited by 25
Chen, K., Wang, Q., Liu, X., Wang, F., Ma, Y., Zhang, S., Shao, Z., Yang, Y., & Tian, X. (2022) · Genes · doi:10.3390/genes13101760 · Cited by 26
A Tumor Microenvironment Model of Pancreatic Cancer to Elucidate Responses toward Immunotherapy
Kast, V., Nadernezhad, A., Pette, D., Gabrielyan, A., Fusenig, M., Honselmann, K. C., Stange, D. E., Werner, C., & Loessner, D. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201907 · Cited by 27
Application of high-throughput single-nucleus DNA sequencing in pancreatic cancer
Zhang, H., Karnoub, E.-R. R., Umeda, S., Chaligné, R., Masilionis, I., McIntyre, C. A., Sashittal, P., Hayashi, A., Zucker, A., Mullen, K. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36344-z · Cited by 24
Self-citationSystemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma
Ma, L. X., Wang, Y., Espin‐Garcia, O., Allen, M. J., Jang, G. H., Zhang, A. X. W., Dodd, A., Ramotar, S., Hutchinson, S., Tehfe, M. A., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02214-0 · Cited by 26
Vallés‐Martí, A., Mantini, G., Manoukian, P., Waasdorp, C., Sarasqueta, A. F., Haas, R. R. D. G., Henneman, A. A., Piersma, S. R., Pham, T. V., Knol, J. C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112581 · Cited by 26
Current status of molecular diagnostic approaches using liquid biopsy
Takahashi, K., Takeda, Y., Ono, Y., Isomoto, H., & Mizukami, Y. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02024-4 · Cited by 26
Woo, W., Carey, E. T., & Choi, M. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s167590 · Cited by 26
Xu, J., Liao, K., Wang, X., He, J., & Wang, X. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16023 · Cited by 26
A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic Cancer
Brouwer, T., Ijsselsteijn, M., Oosting, J., Ruano, D., van der Ploeg, M., Dijk, F., Bonsing, B., Fariña, A., Morreau, H., Vahrmeijer, A., et al. (2022) · Cancers · doi:10.3390/cancers14163862 · Cited by 24
Metadata
- Authors
- Moffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G. H., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., Smyla, J. K., Anderson, J. M., Kim, H. J., Bentrem, D. J., Talamonti, M. S., Iacobuzio-Donahue, C. A., Hollingsworth, M. A., & Yeh, J. J.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- University of Nebraska–Lincoln (US)
- Northwestern University (US)
- Corresponding author
- Yeh, Jen Jen
- ORCID
- Venue
- Nature Genetics
- Published
- 2015-09-07
- Volume
- 47
- Issue
- 10
- Pages
- 1168-1178
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC4912058
- OpenAlex
- W1497915798
- Cited by
- 2,194
- References
- 63
- Citations by year
- 2026: 227 · 2025: 237 · 2024: 236 · 2023: 252 · 2022: 256 · 2021: 298 · 2020: 223 · 2019: 168 · 2018: 124 · 2017: 96 · 2016: 65 · 2015: 9
- FWCI
- 42.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (T32CA009156, R01CA140424, P30CA060553)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK034897, P30DK034987)
- National Institute of Environmental Health Sciences (P30ES010126)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- pancreatic ductal adenocarcinoma, tumor stroma, tumor subtypes, gene expression signatures, blind source separation, basal-like subtype, prognostic subtypes, metastatic pancreatic cancer, molecular classification
- MeSH terms
- Adenocarcinoma, Animals, Female, Humans, Male, Pancreatic Neoplasms, Gene Expression, Stromal Cells, Genetic Heterogeneity, Carcinoma, Pancreatic Ductal, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
